Evidence map›Paper›PMID 37942614›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2024

Platelet Metabolic Profiling Reveals Glycolytic and 1-Carbon Metabolites Are Essential for GP VI-Stimulated Human Platelets-Brief Report.

Madankumar Ghatge, Gagan D Flora, Manasa K Nayak, Anil K Chauhan

Open access · greenAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Madankumar Ghatge *Department of Internal Medicine, Division of Hematology/Oncology, University of Iowa.ORCID 0000-0002-6606-0108
Gagan D FloraDepartment of Internal Medicine, Division of Hematology/Oncology, University of Iowa.ORCID 0000-0002-4784-3094
Manasa K Nayak *Department of Internal Medicine, Division of Hematology/Oncology, University of Iowa.ORCID 0000-0001-6461-0543
Anil K ChauhanDepartment of Internal Medicine, Division of Hematology/Oncology, University of Iowa.ORCID 0000-0001-8554-0898
University of Iowa · US

Funding

Targeting Pyruvate Kinase M2: A novel strategy to combat thrombo-inflammationR35HL139926 · NHLBI · UNIVERSITY OF IOWA · PI CHAUHAN, ANIL KUMAR · 2018 to 2024
$5.3M
The University of Iowa's Regional Stroke Research NetworkU24NS107247 · NINDS · UNIVERSITY OF IOWA · PI ENRIQUE Carlos LEIRA · 2018 to 2026
$2.8M
The University of Iowa Stroke Preclinical Assessment Network to Support Translational Studies for Acute CerebroprotectionU01NS130587 · NINDS · UNIVERSITY OF IOWA · PI CHAUHAN, ANIL KUMAR, LEIRA, ENRIQUE CARLOS · 2023 to 2025
$1.8M
Novel therpeautic interventions to treat ischemic strokeR01NS109910 · NINDS · UNIVERSITY OF IOWA · PI CHAUHAN, ANIL KUMAR · 2019 to 2023
$1.8M
NHLBI NIH HHS R35 HL139926NINDS NIH HHS R01 NS109910NINDS NIH HHS U01 NS130587NINDS NIH HHS U24 NS107247
6 · The paper itself

Abstract

backgroundEvolving evidence suggests that besides signaling pathways, platelet activation involves a complex interplay between metabolic pathways to support thrombus growth. Selective targeting of metabolic checkpoints may inhibit platelet activation and provide a novel antiplatelet strategy. We, therefore, examined global metabolic changes that occur during the transition of human platelets from resting to an activated state to identify metabolites and associated pathways that contribute to platelet activation.

methodsWe performed metabolic profiling of resting and convulxin-stimulated human platelet samples. The differential levels, pathway analysis, and PCA (principal component analysis) were performed using Metaboanalyst. Metascape was used for metabolite network construction.

resultsOf the 401 metabolites identified, 202 metabolites were significantly upregulated, and 2 metabolites were downregulated in activated platelets. Of all the metabolites, lipids scored highly and constituted ≈50% of the identification. During activation, aerobic glycolysis supports energy demand and provides glycolytic intermediates required by metabolic pathways. Consistent with this, an important category of metabolites was carbohydrates, particularly the glycolysis intermediates that were significantly upregulated compared with resting platelets. We found that lysophospholipids such as 1-palmitoyl-GPA (glycero-3-phosphatidic acid), 1-stearoyl-GPS (glycero-3-phosphoserine), 1-palmitoyl-GPI (glycerophosphoinositol), 1-stearoyl-GPI, and 1-oleoyl-GPI were upregulated in activated platelets. We speculated that platelet activation could be linked to 1-carbon metabolism, a set of biochemical pathways that involve the transfer and use of 1-carbon units from amino acids, for cellular processes, including nucleotide and lysophospholipid synthesis. In alignment, based on pathway enrichment and network-based prioritization, the metabolites from amino acid metabolism, including serine, glutamate, and branched-chain amino acid pathway were upregulated in activated platelets, which might be supplemented by the high levels of glycolytic intermediates.

conclusionsMetabolic analysis of resting and activated platelets revealed that glycolysis and 1-carbon metabolism are necessary to support platelet activation.

Indexed as

Blood PlateletsPlatelet ActivationGlycolysisHumansPhosphorylationPlatelet Membrane GlycoproteinsSignal TransductionPlatelet Membrane Glycoproteinsplatelet membrane glycoprotein VI1-carbon metabolismglycolysisglycoprotein VIplatelet activationplatelet metabolism

Identifiers

PMID37942614
PMCPMC10880120
OpenAlexW4388532958

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.